REPLIGEN CORP - COMMON STOCK (RGEN)

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Total 13F shares
32,457,429
Share change
+4,390,417
Total reported value
$1,142,458,808
Put/Call ratio
410%
Price per share
$35.20
Number of holders
177
Value change
+$157,883,467
Number of buys
80
Number of sells
83

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q1 2017

As of 31 Mar 2017, REPLIGEN CORP - COMMON STOCK (RGEN) was held by 177 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,457,429 shares. The largest 10 holders included BlackRock Inc., TimesSquare Capital Management, LLC, OppenheimerFunds, Inc., VANGUARD GROUP INC, Invesco Ltd., FMR LLC, Conestoga Capital Advisors, LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, and Ranger Investment Management, L.P.. This page lists 177 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.